THE INTERPLAY OF INTERLEUKIN-10 (IL-10) AND INTERLEUKIN-2 (IL-2) IN HUMORAL IMMUNE-RESPONSES - IL-10 SYNERGIZES WITH IL-2 TO ENHANCE RESPONSES OF HUMAN B-LYMPHOCYTES IN A MECHANISM WHICH IS DIFFERENT FROM UP-REGULATION OF CD25 EXPRESSION

被引:31
作者
ITOH, K
INOUE, T
ITO, K
HIROHATA, S
机构
[1] TEIKYO UNIV, SCH MED, DEPT INTERNAL MED 2, TOKYO 173, JAPAN
[2] UNIV TOKYO, SCH MED, DEPT MED & PHYS THERAPY, TOKYO 113, JAPAN
关键词
D O I
10.1006/cimm.1994.1243
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of the interplay of interleukin-2 (IL-2) and interleukin-10 (IL-10) in responses of human peripheral blood B cells stimulated by ligation of antigen receptors was examined in detail. Highly purified peripheral blood B cells from normal human individuals were cultured with Staphylococcus aureus Cowan I(SA) in the presence or absence of IL-10 and IL-2. Although IL-10 alone could modestly induce Ig production by SA-activated B cells, IL-10 markedly enhanced the Ig production in synergism with IL-2. This synergistic effect between IL-2 and IL-10 was completely abrogated by addition of either anti-CD25 mAb or anti-IL-10 mAb, indicating signals through high-affinity IL-2 receptors are involved in the synergism. In fact, IL-10 upregulated the expression of alpha-chain of IL-2 receptors (CD25) on B cells stimulated by SA alone or SA + IL-2 for 72 hr. However, such upregulation of CD25 expression did not result in significant enhancement of subsequent responses of the activated B cells to IL-2. Of note, during the initial activation phase of B cells, IL-2 was much more effective than IL-10 in enhancing the subsequent responses to either IL-2 or IL-10. By contrast, IL-10 was much more effective than IL-2 in supporting the maturation of B cells following the initial activation. Finally, the synergy between IL-2 and IL-10 was not observed in the initial activation phase, but in the subsequent maturation phase of activated B cells. These results indicate that IL-10 and IL-2 synergistically enhance Ig production of SA-activated B cells in a mechanism which is different from the upregulation of IL-2 receptors. Moreover, the data emphasize the importance of the interplay of IL-2 and IL-10 in determining the outcome of humoral immune responses. (C) 1994 Academic Press, Inc.
引用
收藏
页码:478 / 488
页数:11
相关论文
共 23 条
[1]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[2]   INTERLEUKIN-10 AND TRANSFORMING GROWTH-FACTOR-BETA COOPERATE TO INDUCE ANTI-CD40 ACTIVATED NAIVE HUMAN B-CELLS TO SECRETE IMMUNOGLOBULIN-A [J].
DEFRANCE, T ;
VANBERVLIET, B ;
BRIERE, F ;
DURAND, I ;
ROUSSET, F ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :671-682
[3]   2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES [J].
FIORENTINO, DF ;
BOND, MW ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2081-2095
[4]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[5]   INTERLEUKIN-10 INDUCES APOPTOTIC CELL-DEATH OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS [J].
FLUCKIGER, AC ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :91-99
[6]   INTERLEUKIN 10 (IL-10) UP-REGULATES FUNCTIONAL HIGH-AFFINITY IL-2 RECEPTORS ON NORMAL AND LEUKEMIC B-LYMPHOCYTES [J].
FLUCKIGER, AC ;
GARRONE, P ;
DURAND, I ;
GALIZZI, JP ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1473-1481
[7]  
FORSGREN A, 1976, EUR J IMMUNOL, V6, P207, DOI 10.1002/eji.1830060312
[8]  
GALILI U, 1974, J IMMUNOL, V112, P1628
[9]   INTERLEUKIN-10, A NOVEL B-CELL STIMULATORY FACTOR - UNRESPONSIVENESS OF X-CHROMOSOME LINKED IMMUNODEFICIENCY-B CELLS [J].
GO, NF ;
CASTLE, BE ;
BARRETT, R ;
KASTELEIN, R ;
DANG, W ;
MOSMANN, TR ;
MOORE, KW ;
HOWARD, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1625-1631
[10]   A SENSITIVE AND SIMPLE METHOD FOR DETERMINATION OF IGM IN CEREBROSPINAL-FLUID BY A SOLID-PHASE ENZYME-IMMUNOASSAY - COMPARISON OF 2 DIFFERENT METHODS [J].
HIROHATA, S ;
YAMADA, A ;
INOUE, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1985, 67 (01) :115-118